Supplementary Figure S10 from Preclinical Antitumor Efficacy of BAY 1129980—a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody–Drug Conjugate for the Treatment of Non–Small Cell Lung Cancer

Autor:	Bertolt Kreft, Karl Ziegelbauer, Rolf Jautelat, Heiner Apeler, Gabriele Leder, Jan Tebbe, Sherif El Sheikh, Rudolf Beier, Frank Dittmer, Jörg Müller, Oliver von Ahsen, Joachim Schuhmacher, Kirk Mclean, Patricia E. Carrigan, Christoph Kneip, Sven Golfier, Claudia Lange, Carol Pena, Beatrix Stelte-Ludwig, Charlotte Kopitz, Hans-Georg Lerchen, Lars Linden, Jörg Willuda
Rok vydání:	2023
DOI:	10.1158/1535-7163.22503553.v1
Popis:	Anti-tumor efficacy of C4.4A-ADC in human nasopharyngeal carcinoma FaDu cancer xenograft mouse model.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981b884f9d85391582eb00cfac0e45ac https://doi.org/10.1158/1535-7163.22503553.v1 Zobrazit plný text záznamu